AI assistant
IMMUNIC, INC. — Regulatory Filings 2021
May 3, 2021
10196_rns_2021-05-03_f522ac4b-e29d-4c5c-8f43-2f7032f92a66.zip
Regulatory Filings
Open in viewerOpens in your device viewer
CORRESP 1 filename1.htm
May 3, 2021
VIA EDGAR
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Christine Westbrook
RE: Immunic, Inc. Registration Statement on Form S-3 File No. 333-255303 Filed April 16, 2021
In accordance with Rule 461 of the Rules and Regulations promulgated under the Securities Act of 1933, as amended, Immunic, Inc. (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement to Wednesday, May 5, at 9:00 a.m., Eastern Time, or as soon as thereafter practicable.
Please call Ilan Katz of Dentons US LLP at (212) 632-5556 to confirm the effectiveness of the Registration Statement or with any questions.
| Very truly yours, |
|---|
| Immunic, Inc. |
| /s/ Daniel Vitt |
| Daniel Vitt |
| President and Chief Executive Officer |